Research Topics
| Laksami N YathamSummaryAffiliation: University of British Columbia Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversiesLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 7:5-69. 2005..These guidelines also discuss issues related to bipolar disorder in women and those with comorbidity and include a section on safety and monitoring...
Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patientsRao N Malempati
Mood and Anxiety Disorders Program, Hotel Dieu Grace Hospital, Windsor, Ontario, Canada
Int Clin Psychopharmacol 23:88-94. 2008..Clinicians may consider risperidone Consta as an option in patients with refractory bipolar illness, including those with a predominantly depressive course, and particularly in patients' nonadherence with prescribed medications...
Quality of life in bipolar disorder: a review of the literatureErin E Michalak
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Health Qual Life Outcomes 3:72. 2005..We identified several important avenues for future research, including a need for more assessment of QoL in hypo/manic patients, more longitudinal research and the development of a disease-specific measure of QoL for patients with BD...
The role of novel antipsychotics in bipolar disordersLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, Vancouver, Canada
J Clin Psychiatry 63:10-4. 2002..Olanzapine, another novel antipsychotic, is also effective against both manic and depressive symptoms and in the maintenance treatment as indicated by an open-label study. Data on other novel agents are more limited...
Efficacy of atypical antipsychotics in mood disordersLakshmi N Yatham
University of British Columbia, Vancouver, Canada
J Clin Psychopharmacol 23:S9-14. 2003....
A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute maniaLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 7:53-7. 2005..To examine the effects of treatment with valproate on brain 5-HT2A receptors in acute manic patients using positron emission tomography (PET) and [18F]-setoperone...
Atypical antipsychotics in bipolar depression: potential mechanisms of actionLakshmi N Yatham
Department of Psychiatry, The University of British Columbia, UBC Hospital, Vancouver, Canada
J Clin Psychiatry 66:40-8. 2005..Further studies should be conducted to examine these hypotheses...
Acute and maintenance treatment of bipolar mania: the role of atypical antipsychoticsLakshmi N Yatham
Mood Disorders Clinical Research Unit, The University of British Columbia, Vancouver, BC, V6T 2A1, Canada
Bipolar Disord 5:7-19. 2003..The atypical antipsychotics represent an effective and relatively safe addition to our armamentarium for the treatment of bipolar disorder...
Translating knowledge of genetics and pharmacology into improving everyday practiceLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 7:13-20. 2005....
Atypical antipsychotics for bipolar disorderLakshmi N Yatham
Mood Disorders Clinical Research Unit, University of British Columbia, Room 2C7 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada
Psychiatr Clin North Am 28:325-47. 2005..Overall, the atypical antipsychotic agents as a group represent an effective and relatively safe addition to the armamentarium for the treatment of bipolar disorder...
Diagnosis and management of patients with bipolar II disorderLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, Vancouver, Canada
J Clin Psychiatry 66:13-7. 2005..Hypomania will likely respond to monotherapy with antimanic agents. Adjunctive psychosocial treatments may provide additional benefit in patients with bipolar II disorder...
Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar maniaLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
J Clin Psychopharmacol 24:599-606. 2004..Quetiapine, in combination with lithium or divalproex, is well tolerated and has superior efficacy to lithium or divalproex alone in the treatment of bipolar mania...
Risperidone in acute and continuation treatment of maniaLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Int Clin Psychopharmacol 18:227-35. 2003..Risperidone add-on does not induce depressive symptoms and, furthermore, risperidone may have efficacy in treating comorbid depressive symptoms in bipolar patients...
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007Lakshmi N Yatham
Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada
Bipolar Disord 8:721-39. 2006..The importance of comorbid psychiatric and medical conditions cannot be understated, and this update provides an expanded look at the prevalence, impact and management of comorbid conditions in patients with bipolar disorder...
Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of maniaLakshmi N Yatham
University of British Columbia, Vancouver, British Columbia Janssen Ortho Inc, Toronto, Canada
Int Clin Psychopharmacol 19:103-9. 2004..These data suggest that risperidone can be safely combined with either lithium or valproate, and that the efficacy is similar regardless of the mood stabilizer used...
The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC)Lakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
Bipolar Disord 12:351-63. 2010....
Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendationsLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, Canada
J Clin Psychiatry 63:275-83. 2002..To review the literature on efficacy of third generation anticonvulsants for treatment of bipolar disorder and provide clinical recommendations...
Quality of life in patients with bipolar I depression: data from 920 patientsLakshmi N Yatham
The University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 6:379-85. 2004..To determine the impact of acute depression on quality of life (QOL) in patients with bipolar I disorder and to compare these results with published data on QOL in patients with unipolar depression...
Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trialLaksami N Yatham
University of British Columbia, Vancouver, Canada
Br J Psychiatry 182:141-7. 2003..Few double-blind trials have examined the efficacy of a combination of a mood stabiliser and an atypical antipsychotic in acute mania...
Mood stabilization and the role of antipsychoticsLakshmi N Yatham
Mood Disorders Clinical Research Unit, Department of Psychiatry, University of British Columbia, Vancouver, Canada
Int Clin Psychopharmacol 17:S21-7. 2002..This article will review the results from open and double-blind studies with quetiapine, ziprasidone, risperidone and olanzapine in the management of bipolar disorder...
Bipolar depression: criteria for treatment selection, definition of refractoriness, and treatment optionsLakshmi N Yatham
Department of Psychiatry, The University of British Columbia, Vancouver, British Columbia, Canada
Bipolar Disord 5:85-97. 2003..This paper reviews controlled studies of bipolar depression, outlines criteria for choosing treatment, defines refractoriness in bipolar depression, and provides options for treatment of refractory bipolar depression...
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar maniaLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, UBC Hospital, Vancouver, British Columbia, Canada
Int Clin Psychopharmacol 22:212-20. 2007..Overall, the combination of quetiapine with lithium or divalproex was well tolerated...
A magnetic resonance imaging study of mood stabilizer- and neuroleptic-naïve first-episode maniaLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 9:693-7. 2007..Studies in first-episode (FE) manic patients have the potential to provide answers to these questions...
Newer anticonvulsants in the treatment of bipolar disorderLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, Vancouver, British Columbia, Canada
J Clin Psychiatry 65:28-35. 2004..This article summarizes current evidence from trials of anticonvulsants in bipolar disorder and makes recommendations for their clinical use...
Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)David J Bond
Mood Disorders Centre, University of British Columbia, Room 2C7 2255 Wesbrook Mall, Vancouver, British Columbia, Canada
J Affect Disord 124:108-17. 2010..However, these reports are limited by retrospective or cross-sectional designs, and the assessment of patients with lengthy illnesses. Prospective data, and data on weight gain early in the course of BD, are lacking...
Pharmacotherapy of bipolar II disorder: a critical review of current evidenceGeorge Hadjipavlou
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Bipolar Disord 6:14-25. 2004..More quality research is needed to delineate effective treatment strategies...
Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania projectMárcia Kauer-Sant'Anna
Department of Psychiatry, Mood Disorders Centre, University of British Columbia, Vancouver, Canada
Compr Psychiatry 50:1-8. 2009..However, there is a relative dearth of research on functional outcomes and their predictors in first-episode manic patients from prospective studies early in the course of bipolar disorder...
Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania projectLakshmi N Yatham
Mood Disorders Program, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia V6T 2A1
Can J Psychiatry 54:105-12. 2009..To describe clinical characteristics, course, and outcome during a 1-year period after the first manic episode in patients with bipolar disorder (BD)...
PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodiumLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Am J Psychiatry 159:768-74. 2002....
Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophreniaCarol J Lane
Department of Psychiatry, University of British Columbia, Vancouver, BC
J Psychiatry Neurosci 29:30-7. 2004....
Lamotrigine for bipolar disorder: translating research into clinical practiceJonathan Fung
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Expert Rev Neurother 4:363-70. 2004..Practical recommendations regarding titration and the management of rash are offered...
Comorbidity in bipolar disorder: a framework for rational treatment selectionRoger S McIntyre
Mood Disorder Psychopharmacology Unit, University of Toronto, University Health Network Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario M5T 2S9, Canada
Hum Psychopharmacol 19:369-86. 2004..This schema should be further informed by the treatment data for comorbid and accessory conditions. The authors propose a schema to provide the impetus for further work in the area...
PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic maniaLakshmi N Yatham
Mood Disorders Clinical Research Unit, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 2A1
Am J Psychiatry 159:1718-23. 2002..The purpose of this study was to further examine D(2) receptor density in a larger sample of nonpsychotic manic patients by using positron emission tomography (PET) and [(11)C]raclopride...
The impact of bipolar disorder upon work functioning: a qualitative analysisErin E Michalak
Division of Mood Disorders, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
Bipolar Disord 9:126-43. 2007..In order to further elucidate the relationship between BD and work, we report here on a series of exploratory qualitative interviews undertaken to develop a disease-specific measure of quality of life in BD...
A comparison of personality function among patients with seasonal depression, nonseasonal depression, and nonclinical participantsErin E Michalak
Department of Psychiatry, University of British Columbia, Vancouver, Canada
J Pers Disord 18:448-58. 2004..The results demonstrated that the traits associated with seasonal and nonseasonal depression differ in degree, not kind...
Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studiesKaveh M Koochesfahani
Pacific Parkinson s Research Centre, University of British Columbia, Vancouver, British Columbia, Canada
Mov Disord 21:970-5. 2006..Our data provide in vivo neurochemical support for the lack of clinical efficacy following MP in PD patients and are also in keeping with reduced DA release following amphetamine in PD subjects...
Bipolar disorder and quality of life: a patient-centered perspectiveErin E Michalak
Division of Mood Disorders, Department of Psychiatry, University of British Columbia, Vancouver, BC V6T 2A1, Canada
Qual Life Res 15:25-37. 2006..We report here on a series of in-depth qualitative interviews we conducted as part of the item generation phase for a disease-specific scale to assess QoL in BD...
Polytherapy in bipolar disorderDaniel Lin
Department of Psychiatry, University of British Columbia, Vancouver, Canada
CNS Drugs 20:29-42. 2006..Similarly, the combination of lithium or valproate plus olanzapine seems to be more effective than monotherapy with a mood stabiliser in preventing manic episodes...
Oxcarbazepine in the treatment of bipolar disorder: a reviewWetid Pratoomsri
Mood Disorders Centre of Excellence, University of British Columbia, Vancouver
Can J Psychiatry 51:540-5. 2006....
Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depressionRaymond W Lam
Division of Clinical Neuroscience, Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 2A1 Canada
J Clin Psychiatry 65:337-40. 2004..In this study, we compared the effects of combining citalopram and bupropion-SR versus switching to the other monotherapy in treatment-resistant depression...
A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorderRaymond W Lam
Department of Psychiatry, University of BC, Mood Disorders Centre, UBC Hospital, Vancouver, Canada
BMC Psychiatry 9:78. 2009..This study seeks to validate the Lam Employment Absence and Productivity Scale (LEAPS), a 10-item self-report questionnaire that takes 3-5 minutes to complete...
Hard times and good friends: negative life events and social support in patients with seasonal and nonseasonal depressionErin E Michalak
Department of Psychiatry, University of British Columbia UBC Hospital, VCHA, Vancouver, British Columbia
Can J Psychiatry 49:408-11. 2004..This study aimed to compare baseline levels of negative life events (NLEs) and perceived social support (SS) in patients with seasonal and nonseasonal depression...
Generic and health-related quality of life in patients with seasonal and nonseasonal depressionErin E Michalak
Division of Clinical Neuroscience, Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 2A1
Psychiatry Res 128:245-51. 2004..Future research is required to determine whether perceived QoL is improved by treatment interventions for seasonal depression such as light therapy or antidepressant medication...
Perceived quality of life in patients with bipolar disorder. Does group psychoeducation have an impact?Erin E Michalak
Department of Psychiatry, University of British Columbia, Vancouver
Can J Psychiatry 50:95-100. 2005..We aimed to assess the impact of a time-limited psychoeducation (PE) group therapy upon perceived QoL among patients with BD...
Brain serotonin-2 receptors in acute maniaLakshmi N Yatham
Mood Disorders Program, University of British Columbia, Vancouver, Canada
Br J Psychiatry 196:47-51. 2010..Although 5-hydroxytryptamine (5-HT) has been implicated in mania, the precise alterations in the 5-HT system remain elusive...
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Lakshmi N Yatham
Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada
Bipolar Disord 11:225-55. 2009..Bipolar II disorder is frequently overlooked in treatment guidelines, but has an important clinical impact on patients' lives. This update provides an expanded look at bipolar II disorder...
Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episodeIvan J Torres
Research Department, Riverview Hospital, British Columbia Mental Health and Addictions Services, Coquitlam, British Columbia, Canada
J Clin Psychiatry 71:1234-42. 2010..The purpose of this study was to determine whether neuropsychological impairments are present in clinically stable patients with bipolar disorder shortly after resolution of their first manic episode...
Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysisDavid J Bond
Mood Disorders Centre, University of British Columbia, Room 2C7 2255 Wesbrook Mall, Vancouver, BC Canada V6T 2A1
J Affect Disord 124:228-34. 2010....
Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depressionLakshmi N Yatham
UBC Department of Psychiatry, The University of British Columbia, UBC Hospital, 2255 Wesbrook Mall, Vancouver, BC V6T2A1, Canada
Br J Psychiatry 196:474-9. 2010..Positron emission tomography (PET) studies in individuals with depression confirmed that antidepressant medications reduce brain 5-HT(2) receptors, but the effects of ECT on these receptors in individuals with depression are unknown...
Oxcarbazepine add-on in the treatment of refractory bipolar disorderWetid Pratoomsri
Mood Disorders Clinical Research Unit, The University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 7:37-42. 2005..CONCLUSION: OXC was effective and well-tolerated in refractory BD and schizoaffective disorder. These preliminary data are promising but controlled studies are needed to confirm its efficacy in refractory BD...
Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysisDavid J Bond
Research and International Affairs, Mood Disorders Centre, Department of Psychiatry, University of British Columbia, Room 2C7, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1 Canada
J Clin Psychiatry 69:1589-601. 2008..The risk of antidepressant-associated mood elevations (AAME) in bipolar II disorder relative to bipolar I disorder and MDD is unknown...
The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)David J Bond
Department of Psychiatry, Mood Disorders Centre, University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 12:616-26. 2010..Obesity in the general population is also consistently associated with functional impairment, but the relationship between weight gain and functional outcomes in BD-I has received little attention...
Bipolar II disorder: an overview of recent developmentsGeorge Hadjipavlou
Department of Psychiatry, University of British Columbia, Vancouver
Can J Psychiatry 49:802-12. 2004..More well-designed studies with larger samples are needed to improve the evidence base for managing this disorder...
Advances in treatment of mood and anxiety disorders: focus on atypical antipsychoticsLakshmi N Yatham
University of British Columbia, Vancouver, BC
Bipolar Disord 5:5-6. 2003
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorderMárcia Kauer-Sant'Anna
Mood Disorders Centre, Department of Psychiatry, University of British Columbia, Vancouver, Canada
Int J Neuropsychopharmacol 12:447-58. 2009..Failure of inflammatory defences in the late stage of the disorder may account for reduction in BDNF and continued elevations in cytokines; thus these may have the potential to serve as markers of illness progression in BD...
Mirtazapine for treatment-resistant depression: a preliminary reportDante D C Wan
Division of Mood Disorders, Department of Psychiatry, University of British Columbia and UBC Hospital, Vancouver, BC
J Psychiatry Neurosci 28:55-9. 2003..Further controlled studies are required to demonstrate the efficacy of mirtazapine in treatment-resistant depression...
Emotional memory in bipolar disorderMárcia Kauer-Sant'Anna
Mood Disorders Centre, University of British Columbia, 2C7 2255 Wesbrook Mall, Vancouver, Canada V6T 2A1
Br J Psychiatry 192:458-63. 2008..Cognitive impairment has been well documented in bipolar disorder. However, specific aspects of cognition such as emotional memory have not been examined...
3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorderAna Cristina Andreazza
Department of Psychiatry, University of British Columbia, BC, Canada
J Psychiatry Neurosci 34:263-71. 2009....
Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysisRaymond W Lam
Division of Clinical Neuroscience, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia
Can J Psychiatry 53:621-31. 2008..None have specifically examined outcomes in patients with treatment-resistant depression (TRD)...
Oxidative stress markers in bipolar disorder: a meta-analysisAna C Andreazza
Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
J Affect Disord 111:135-44. 2008..In the present investigation, we conducted a meta-analysis of studies that evaluated markers of oxidative stress in individuals with BD, as compared to healthy controls...
Does neuroimmune dysfunction mediate seasonal mood changes in winter depression?Raymond W Lam
Division of Clinical Neuroscience, Department of Psychiatry, University of British Columbia UBC, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 2A1
Med Hypotheses 63:567-73. 2004..The etiology of winter depression (seasonal affective disorder, or SAD) is not known, but a number of studies have provided support for both photoperiod and neurotransmitter hypotheses...
Recovery and functional outcomes following olanzapine treatment for bipolar I maniaK N Roy Chengappa
Western Psychiatric Institute and Clinic, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15213 2593, USA
Bipolar Disord 7:68-76. 2005..Typical experimental categorizations of treatment responses in bipolar disorder (BPD) patients may have limited relationship to clinical recovery or functional status, and there is inadequate research on such clinically important outcomes...
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trialMauricio Tohen
Lilly Research Laboratories, Indianapolis, IN 46285, USA
Am J Psychiatry 162:1281-90. 2005..The authors compared the efficacy of olanzapine and lithium in the prevention of mood episode relapse/recurrence...
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorderJoseph R Calabrese
University Hospitals of Cleveland Case Western Reserve School of Medicine, Department of Psychiatry, 11400 Euclid Ave, Ste 200, Cleveland, OH 44106, USA
J Clin Psychiatry 64:1013-24. 2003..This study assessed the efficacy and tolerability of lamotrigine and lithium compared with placebo for the prevention of mood episodes in bipolar disorder...
Olanzapine versus placebo in acute mania: treatment responses in subgroupsRoss J Baldessarini
International Consortium for Bipolar Disorder Research, Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA
J Clin Psychopharmacol 23:370-6. 2003..5-1.7, all P < 0.01). These well-powered comparisons of subgroups of interest indicate broad efficacy of olanzapine in the treatment of acute mania...
International Consensus Group on Bipolar I Depression Treatment GuidelinesJoseph R Calabrese
Department of Psychiatry, Case Western Reserve University, Cleveland, OH, USA
J Clin Psychiatry 65:571-9. 2004
Bipolar spectrum disorders. New perspectivesAndre Piver
Nelson Mental Health Centre, Kootenay Lake Regional Hospital, Nelson, BC
Can Fam Physician 48:896-904. 2002..To review new perspectives on diagnosis, clinical features, epidemiology, and treatment of bipolar II and related disorders...
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorderCharles L Bowden
Department of Psychiatry, University of Texas Health Science Center at San Antonio, 78229, USA
Arch Gen Psychiatry 60:392-400. 2003....
Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trialsMark A Frye
Mood Disorders Research Program, University of California at Los Angeles, USA
J Clin Psychiatry 67:1721-8. 2006..Subsyndromal symptoms in bipolar disorder can cause significant functional impairment and are associated with relapse...
Electroretinography in patients with winter seasonal affective disorderMarc Hebert
Department of Ophthalmology, Laval University Medical Research Center CHUQ, Faculty of Medicine, Laval University, Sainte Foy, Quebec, Canada
Psychiatry Res 127:27-34. 2004..We hypothesize that brain neurotransmitter dysregulation may be at the origin of both the mood disorder and retinal sensitivity change...
Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar maniaK N Roy Chengappa
Western Psychiatric Institute and Clinic, Mayview State Hospital, University of Pittsburgh Medical Center, PA 15213 2593, USA
Bipolar Disord 5:1-5. 2003....
Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathologyJuliana Tramontina
Post Graduate Biochemistry Program, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
Bipolar Disord 9:128-35. 2007....
Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled dataEduard Vieta
Bipolar Disorders Program, Department of Psychiatry, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain
J Clin Psychiatry 65:1420-8. 2004..We report on the first controlled study comparing acute and continuous clinical outcomes in RC and non-RC manic patients treated with olanzapine...
Setting the stage: from prodrome to treatment resistance in bipolar disorderMichael Berk
Barwon Health and The Geelong Clinic, Geelong, Victoria, Australia
Bipolar Disord 9:671-8. 2007..At the other end of the spectrum, the model attempts to operationalize treatment resistance. The utility of the model will need to be validated by empirical research...
Pure and mixed manic subtypes: a review of diagnostic classification and validationFrederick Cassidy
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
Bipolar Disord 10:131-43. 2008..To review issues surrounding the diagnosis and validity of bipolar manic states...
Comment on "Antidepressant treatment-emergent switch in bipolar disorder: a prospective case-control study of outcome"Lakshmi N Yatham
Rev Bras Psiquiatr 29:86-7; author reply 87-8. 2007
Effect of valproate on plasma levels of interleukin-6 in healthy male humansI Shin Shiah
Department of Psychiatry, Tri Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Int Clin Psychopharmacol 20:295-8. 2005....
Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force ReportS Nassir Ghaemi
Bipolar Disorder Research Program, Department of Psychiatry, Emory University, Atlanta, GA 30322, USA
Bipolar Disord 10:117-28. 2008....
Effect of lamotrigine on plasma GABA levels in healthy humansI Shin Shiah
Department of Psychiatry, Tri Service General Hospital, No 325, Cheng Gung Road, Sec 2, Nei Hu District, 114, Taipei, Taiwan
Prog Neuropsychopharmacol Biol Psychiatry 27:419-23. 2003..The finding of this study suggests that lamotrigine in the dose used in this study does not appear to enhance GABA levels in humans...
Psychosocial outcomes following electroconvulsive therapy in a community setting: retrospective chart review with 2-year follow-upBiju Mathew
Ridge Meadows Hospital, Fraser Health Authority, Maple Ridge, British Columbia
Can J Psychiatry 52:598-604. 2007..This study aimed to examine these outcomes in short- and long-term naturalistic follow-up of ECT conducted in a community hospital...
